It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Deciding between cash back and rewards credit cards? This guide helps you compare features to find the best option for your financial goals.
26,399 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Merck stock jumps on a major restructuring, but Reddit sentiment shows growing skepticism as investors weigh Keytruda...
When a beloved star dies unexpectedly, fans feel the loss in many ways—including financially. This article distills p...
Investors chase a steady $2,000 monthly dividend income amid evolving rates in 2026. This report outlines the math, c...
The Dow's milestone moment signals more than pride for bulls. This guide breaks down why Nvidia and Broadcom led the ...
As GLP-1 therapies reshape obesity treatment, investors eye the best weight loss drug stock bets for 2026. This guide...
Strategy Inc. disclosed a rare bitcoin sale, sending its stock lower as investors weigh liquidity needs against the c...
An insider at Rackspace Technology recently disclosed a significant stock sale. This article explains what that means...
When a foreign gift becomes a temporary presidential plane, it illuminates how public spending, asset management, and...
Dell is closing in on its 52-week high as AI server demand lifts results, prompting investors to weigh whether to buy...
When life tests a family, money becomes a shared tool. This article draws on the idea behind john stamos says family ...
Root Insurance posted its first underwriting profit in 2025, delivering $40.3 million in net income on $1.5 billion i...